Skin and hair

87 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Skin and hair
Treatment and conditionWhere it standsTrials
Abrocitinib for eczemaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
ABS-201 SC Multiple Doses + Placebo SC Injection for alopeciaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
AD-303A for alopeciaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Adalimumab for alopeciaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
AdMSC for scleroderma, systemicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Amlitelimab for eczemaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Anti Thymocyte Globulin + GM-CSF + Total Body Irradiation + ALEMTUZUMAB + RITUXIMAB + HUMAN IMMUNOGLOBULIN G + Cyclophosphamide + THIOTEPA + Mesna for scleroderma, diffusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
anti-CD19 CAR-T cells for scleroderma, systemicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
ATI-045 for eczemaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ATTO-1310 for pruritusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
AZD0120 for scleroderma, systemicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Baricitinib for alopeciaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Baricitinib for alopecia areataTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Belimumab for scleroderma, diffusePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Beremagene geperpavec for epidermolysis bullosa dystrophicaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bimekizumab for psoriasisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Blood Specimen Collection + Photographs of Rash + Questionnaires + Stool Specimen collection + Doxycycline for acneiform eruptionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Blood Specimen Collection + Photographs of Rash + Questionnaires + Stool Specimen collection + Isotretinoin for acneiform eruptionsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Botulinum toxin type a for alopeciaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
CAR-T cells targeting CD19 for scleroderma, systemicTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Clinical decision support tool for keratosis, seborrheicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Crisaborole 2% topical ointment for vitiligoPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Cyclophosphamide + FLUDARABINE + Prulacabtagene Leucel for scleroderma, systemicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
DB-2304 + Placebo for lupus erythematosus, cutaneousPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
DB-2304 + Placebo + Prednisone for lupus erythematosus, cutaneousPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deucravacitinib for psoriasisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deucravacitinib for vitiligoPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deuruxolitinib for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Diacerein for epidermolysis bullosa simplexPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dupilumab for dermatitisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dupilumab for eczemaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)7
Famotidine and 4% topical cromolyn sodium for pruritusPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Gentamicin for ichthyosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High-intensity Mediterranean diet intervention for psoriasisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for alopeciaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (hUC-MSC-Exos) Intravenous Infusion for vitiligoTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (hUC-MSC-Exos) Local Injection for vitiligoTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Lactiplantibacillus plantarum for psoriasisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lebrikizumab for dermatitisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lebrikizumab for eczemaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Lenalidomide for lupus erythematosus, cutaneousTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Mesenchymal Stem Cells for alopeciaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Metformin for melanosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Minoxidil for alopeciaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
MTX-474 for scleroderma, diffusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Music Therapy for psoriasisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Neolizumab for epidermolysis bullosa dystrophicaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Neolizumab for pruritusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Neovasculgen® for foot ulcerPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Optical Coherence Tomography + Reflectance confocal microscopy + DUPILUMAB for eczemaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for eczemaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Placebo for pruritusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo - 100 mg + Ritlecitinib 50 mg for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo - 50 mg + Ritlecitinib 100 mg for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + DUPILUMAB for eczemaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + LEBRIKIZUMAB for eczemaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo + Upadacitinib for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo IV + SAD IV Dose 1 - 150mg ABS201 IV Single Dose for alopeciaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
PP405 0.05% Topical Gel for alopeciaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
PTX-022 for pachyonychia congenitaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
QEL-005 for scleroderma, diffusePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Risankizumab for psoriasisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ritlecitinib 100 mg for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Rituximab + belimumab for scleroderma, systemicPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Roflumilast for dermatitis, seborrheicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Roflumilast for psoriasisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ruxolitinib for lichen sclerosus et atrophicusPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ruxolitinib for vitiligoPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Saccharomyces cerevisiae for ichthyosis bullosa of siemensPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Scar gel for keloidPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Small interfering RNA (siRNA) Microneedle Patches for keloidTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
SPY002-072 for collagen diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Suzetrigine for breast diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Suzetrigine for nail diseasesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tapinarof for keratoderma, palmoplantarPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
TAR-0520 gel for hand-foot syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Telitacicept for scleroderma, diffusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Topical emollient (moisturizer) + DUPILUMAB for pruritusPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tranexamic acid for hyperpigmentationPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tulisokibart for scleroderma, diffusePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Upadacitinib for alopecia areataPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Ustekinumab for alopeciaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VDPHL01 for alopeciaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
VDPHL01 BID for alopeciaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
VDPHL01 QD for alopeciaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zasocitinib for psoriasisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1